SEC Form 4 · accession 0001209191-18-061804
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie McHugh
Director
Period of report
Dec 6, 2018
Accepted (ET)
Dec 10, 2018 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 6, 2018 | S | 1,500 | $12.46 | D | 89,631 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.